Jain A, Mishra A, Hurkat P, Shilpi S, Mody N, Jain S
Drug Deliv Transl Res. 2025; .
PMID: 39847205
DOI: 10.1007/s13346-024-01780-x.
Asgharzadeh F, Moradi Binabaj M, Fanoudi S, Cho W, Yang Y, Azarian M
Adv Pharm Bull. 2024; 14(3):513-523.
PMID: 39494254
PMC: 11530870.
DOI: 10.34172/apb.2024.061.
Allam E, Darwish M, Abou Khalil N, El-Baset S, El-Aal M, Elrawy A
BMC Pharmacol Toxicol. 2024; 25(1):74.
PMID: 39380023
PMC: 11460069.
DOI: 10.1186/s40360-024-00795-x.
Ten Hove M, Smyris A, Booijink R, Wachsmuth L, Hansen U, Alic L
Bioact Mater. 2024; 39:406-426.
PMID: 38855059
PMC: 11157122.
DOI: 10.1016/j.bioactmat.2024.05.034.
Kusumoputro S, Au C, Lam K, Park N, Hyun A, Kusumoputro E
Nanomaterials (Basel). 2024; 14(1).
PMID: 38202522
PMC: 10780512.
DOI: 10.3390/nano14010067.
Self-assembled FGF21 nanoparticles alleviate drug-induced acute liver injury.
Huang Z, Wang H, Chun C, Li X, Xu S, Zhao Y
Front Pharmacol. 2023; 13:1084799.
PMID: 36703750
PMC: 9871310.
DOI: 10.3389/fphar.2022.1084799.
Polymeric nanomedicines for the treatment of hepatic diseases.
Luo F, Yu Y, Li M, Chen Y, Zhang P, Xiao C
J Nanobiotechnology. 2022; 20(1):488.
PMID: 36402994
PMC: 9675156.
DOI: 10.1186/s12951-022-01708-y.
Biodistribution Profile of Magnetic Nanoparticles in Cirrhosis-Associated Hepatocarcinogenesis in Rats by AC Biosusceptometry.
Soares G, Pereira G, Romualdo G, Biasotti G, Stoppa E, Bakuzis A
Pharmaceutics. 2022; 14(9).
PMID: 36145654
PMC: 9504370.
DOI: 10.3390/pharmaceutics14091907.
A systematic review and meta-analysis of endocrine-related adverse events associated with interferon.
Wang L, Li B, Zhao H, Wu P, Wu Q, Chen K
Front Endocrinol (Lausanne). 2022; 13:949003.
PMID: 35992107
PMC: 9388759.
DOI: 10.3389/fendo.2022.949003.
Circumsporozoite Protein of - and George Baker Virus A-Derived Peptides Trigger Efficient Cell Internalization of Bioconjugates and Functionalized Poly(ethylene glycol)--poly(benzyl malate)-Based Nanoparticles in Human Hepatoma Cells.
Vene E, Jarnouen K, Ribault C, Vlach M, Verres Y, Bourgeois M
Pharmaceutics. 2022; 14(4).
PMID: 35456637
PMC: 9028075.
DOI: 10.3390/pharmaceutics14040804.
Pharmacotherapies for Drug-Induced Liver Injury: A Current Literature Review.
Li M, Luo Q, Tao Y, Sun X, Liu C
Front Pharmacol. 2022; 12:806249.
PMID: 35069218
PMC: 8766857.
DOI: 10.3389/fphar.2021.806249.
Targeted drug delivery strategies for precision medicines.
Manzari M, Shamay Y, Kiguchi H, Rosen N, Scaltriti M, Heller D
Nat Rev Mater. 2021; 6(4):351-370.
PMID: 34950512
PMC: 8691416.
DOI: 10.1038/s41578-020-00269-6.
Development of Polymer-Based Nanoformulations for Glioblastoma Brain Cancer Therapy and Diagnosis: An Update.
Rabha B, Bharadwaj K, Pati S, Choudhury B, Sarkar T, Abdul Kari Z
Polymers (Basel). 2021; 13(23).
PMID: 34883617
PMC: 8659151.
DOI: 10.3390/polym13234114.
Efficacy of Ursolic Acid-Enriched Water-Soluble and Not Cytotoxic Nanoparticles against Enterococci.
Schito A, Caviglia D, Piatti G, Zorzoli A, Marimpietri D, Zuccari G
Pharmaceutics. 2021; 13(11).
PMID: 34834390
PMC: 8625572.
DOI: 10.3390/pharmaceutics13111976.
Applications of Nanobiomaterials in the Therapy and Imaging of Acute Liver Failure.
Jin Y, Wang H, Yi K, Lv S, Hu H, Li M
Nanomicro Lett. 2021; 13(1):25.
PMID: 34138224
PMC: 8187515.
DOI: 10.1007/s40820-020-00550-x.
Crizotinib and Doxorubicin Cooperatively Reduces Drug Resistance by Mitigating MDR1 to Increase Hepatocellular Carcinoma Cells Death.
Shao M, Shi R, Gao Z, Gao S, Li J, Li H
Front Oncol. 2021; 11:650052.
PMID: 34094940
PMC: 8170002.
DOI: 10.3389/fonc.2021.650052.
Antioxidant and C5a-blocking strategy for hepatic ischemia-reperfusion injury repair.
Zhang X, Hu J, Becker K, Engle J, Ni D, Cai W
J Nanobiotechnology. 2021; 19(1):107.
PMID: 33858424
PMC: 8050892.
DOI: 10.1186/s12951-021-00858-9.
Synthesis of FeO/Ag nanohybrid ferrofluids and their applications as antimicrobial and antifibrotic agents.
Taufiq A, Saputro R, Susanto H, Hidayat N, Sunaryono S, Amrillah T
Heliyon. 2021; 6(12):e05813.
PMID: 33426329
PMC: 7779699.
DOI: 10.1016/j.heliyon.2020.e05813.
Recent Advances in Nanomedicine for the Diagnosis and Therapy of Liver Fibrosis.
Bai X, Su G, Zhai S
Nanomaterials (Basel). 2020; 10(10).
PMID: 33003520
PMC: 7599596.
DOI: 10.3390/nano10101945.
Advanced Therapeutics, Vaccinations, and Precision Medicine in the Treatment and Management of Chronic Hepatitis B Viral Infections; Where Are We and Where Are We Going?.
Duraisamy G, Bhosale D, Lipenska I, Huvarova I, Ruzek D, Windisch M
Viruses. 2020; 12(9).
PMID: 32906840
PMC: 7552065.
DOI: 10.3390/v12090998.